NASDAQ:IMACIMAC Stock Price, Forecast & News

IMAC's stock was trading at $0.82 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IMAC stock has increased by 84.1% and is now trading at $1.51. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IMAC in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for IMAC.

IMAC is scheduled to release its next quarterly earnings announcement on Friday, August 21st 2020. View our earnings forecast for IMAC.

IMAC Holdings Inc (NASDAQ:IMAC) posted its quarterly earnings results on Thursday, May, 14th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.17) by $0.01. The firm had revenue of $3.32 million for the quarter, compared to analyst estimates of $5.72 million. IMAC had a negative return on equity of 80.08% and a negative net margin of 41.20%. View IMAC's earnings history.

2 brokerages have issued 12-month target prices for IMAC's shares. Their forecasts range from $4.50 to $4.50. On average, they expect IMAC's stock price to reach $4.50 in the next twelve months. This suggests a possible upside of 198.0% from the stock's current price. View analysts' price targets for IMAC.

News headlines about IMAC stock have been trending very positive on Tuesday, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. IMAC earned a coverage optimism score of 3.5 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutIMAC.

IMAC saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 46,800 shares, a drop of 45.8% from the April 30th total of 86,400 shares. Based on an average daily trading volume, of 1,070,000 shares, the short-interest ratio is presently 0.0 days. Approximately 0.9% of the shares of the stock are sold short. View IMAC's Current Options Chain.

Some companies that are related to IMAC include Acadia Healthcare (ACHC), BioTelemetry (BEAT), Hanger (HNGR), Biocorrx (BICX) and AAC (AAC). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other IMAC investors own include NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Amarin (AMRN), VBI Vaccines (VBIV), Advanced Micro Devices (AMD), Aytu Bioscience (AYTU), Crispr Therapeutics (CRSP), Vaxart (VXRT), Agile Therapeutics (AGRX) and Armata Pharmaceuticals (ARMP).

(IMAC) raised $4 million in an initial public offering on the week of February 11th 2019. The company issued 900,000 shares at a price of $5.00 per share. Dawson James Securities and Cuttone served as the underwriters for the IPO.

IMAC trades on the NASDAQ under the ticker symbol "IMAC."

Shares of IMAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of IMAC stock can currently be purchased for approximately $1.51.

IMAC has a market capitalization of $15.11 million and generates $15.13 million in revenue each year. The company earns $-6,500,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis.

The official website for IMAC is www.imacregeneration.com.

IMAC's mailing address is 1605 WESTGATE CIRCLE, BRENTWOOD TN, 37027. The company can be reached via phone at 844-266-4622 or via email at [email protected]